Skip to content

Portable Cardiopulmonary Assessment in ILD: Prospective Interventional Study Comparing Three Exercise Testing Modalities

Portable Cardiopulmonary Assessment in ILD: Prospective Interventional Study Comparing Three Exercise Testing Modalities - Portable Cardiopulmonary Assessment in ILD: Prospective Interventional Study Comparing Three Exercise Testing Modalities

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000058488
Enrollment
60
Registered
2025-07-16
Start date
2021-04-15
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Interstitial Lung Disease

Interventions

Participants will wear a portable respiratory gas exchange analyzer and perform three types of exercise tests.

Sponsors

Kanagawa Cardiovascular and Respiratory Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients will be deemed eligible for the study if they are diagnosed with interstitial lung disease, clinically stable, and have no pulmonary rehabilitation session for the passed 6 months.

Exclusion criteria

Exclusion criteria: People with CRD will be excluded if they (i) have the potential to cause significant hypoxemia with exercise; (ii) require nasal cannula oxygenation (including home oxygen therapy) ; (iii) have complications or disabilities that make exercise difficult; (iv) have cardiac disease that puts participants at risk for exercise; (v) forbidden by their doctors to exercise; (vi) have inadequate understanding of exercise stress testing; (vii) are diagnosed with dementia; (viii) have visual or hearing problems in performing exercise training

Design outcomes

Primary

MeasureTime frame
peak oxygen uptake, anaerobic metabolic threshold, peak work rate, VE/VCO2 for each exercise test

Countries

Japan

Contacts

Public ContactAtsuhito Nakazawa

Kanagawa Cardiovascular and Respiratory Center Department of Respiratory Medicine

gda_kawasaki@yahoo.co.jp045-701-9581

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Sep 19, 2026